Spots Global Cancer Trial Database for cca
Every month we try and update this database with for cca cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS) | NCT02082522 | Hilar Cholangio... | Photodynamic th... Stenting proced... Chemotherapy re... | 18 Years - | Concordia Laboratories Inc. | |
| Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer | NCT05239169 | Biliary Tract C... Intrahepatic Ch... Hilar Cholangio... Distal Cholangi... Gall Bladder Ca... | Durvalumab Tremelimumab Capecitabine | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Expanded Access Study of TAS-120 in Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements | NCT04507503 | Advanced Cholan... | TAS-120 | 18 Years - | Taiho Oncology, Inc. | |
| Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer | NCT05239169 | Biliary Tract C... Intrahepatic Ch... Hilar Cholangio... Distal Cholangi... Gall Bladder Ca... | Durvalumab Tremelimumab Capecitabine | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Rearrangement | NCT04256980 | Cholangiocarcin... | Pemigatinib | 18 Years - | Innovent Biologics (Suzhou) Co. Ltd. | |
| Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS) | NCT02082522 | Hilar Cholangio... | Photodynamic th... Stenting proced... Chemotherapy re... | 18 Years - | Concordia Laboratories Inc. | |
| A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas | NCT01900158 | Cholangiocarcin... | Amphinex, Gemci... | 18 Years - | PCI Biotech AS | |
| A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas | NCT01900158 | Cholangiocarcin... | Amphinex, Gemci... | 18 Years - | PCI Biotech AS | |
| Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS) | NCT02082522 | Hilar Cholangio... | Photodynamic th... Stenting proced... Chemotherapy re... | 18 Years - | Concordia Laboratories Inc. | |
| An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma | NCT05876754 | Cholangiocarcin... | Ivosidenib Oral... | 18 Years - | Servier | |
| Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Rearrangement | NCT04256980 | Cholangiocarcin... | Pemigatinib | 18 Years - | Innovent Biologics (Suzhou) Co. Ltd. | |
| Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers | NCT04645160 | Cholangiocarcin... Bile Duct Neopl... Biliary Tract M... | Tivozanib | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer | NCT05239169 | Biliary Tract C... Intrahepatic Ch... Hilar Cholangio... Distal Cholangi... Gall Bladder Ca... | Durvalumab Tremelimumab Capecitabine | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Expanded Access Study of TAS-120 in Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements | NCT04507503 | Advanced Cholan... | TAS-120 | 18 Years - | Taiho Oncology, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
